Stay updated on HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The date '2025-03-04' has been added, while '2024-05-22' has been removed from the page.
    Difference
    1.0%
    Check dated 2025-03-11T00:33:34.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-03-03T22:26:56.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-10T10:55:27.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T09:51:31.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-20T00:56:45.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    1.0%
    Check dated 2025-01-12T20:40:53.000Z thumbnail image

Stay in the know with updates to HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial page.